Bhopal (Madhya Pradesh) [India], May 1 (ANI): All India Institute of Medical Sciences Bhopal has begun the clinical trial of the drug Mycobacterium (Mw) on a COVID-19 patient on Thursday.
Bhopal (Madhya Pradesh) [India], April 30 (ANI): A multicentric study on the use Mycobacterium w (Mw), heat-killed Mycobacterium indicus pranii, as an adjunct to the treatment of coronavirus is being conducted at AIIMS Bhopal with the approval of Drug Controller General of India.
New Delhi [India], April 28 (ANI): The Council of Scientific and Industrial Research (CSIR) Director Shekhar Mande on Monday said that trial of Mycobacterium w (Mw) has started.
New Delhi [India], April 26 (ANI): Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh and AIIMS Delhi and Bhopal will study the effectiveness of Mycobacterium w in critical COVID-19 patients.
New Delhi [India], April 19 (ANI): Council of Scientific and Industrial Research (SCIR) Director-General Dr Shekhar C Mande on Sunday said that the institute is currently testing Mycobacterium w (Mw), which is a vaccine for leprosy, to treat COVID-19.